DK1841874T3 - Leadersekvenser til at lede secernering af polypeptider og fremgangsmåder til fremstilling heraf - Google Patents
Leadersekvenser til at lede secernering af polypeptider og fremgangsmåder til fremstilling herafInfo
- Publication number
- DK1841874T3 DK1841874T3 DK06719694.9T DK06719694T DK1841874T3 DK 1841874 T3 DK1841874 T3 DK 1841874T3 DK 06719694 T DK06719694 T DK 06719694T DK 1841874 T3 DK1841874 T3 DK 1841874T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- methods
- heterologous
- preparation
- nucleic acid
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 230000028327 secretion Effects 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64701305P | 2005-01-27 | 2005-01-27 | |
| PCT/US2006/002951 WO2006081430A2 (en) | 2005-01-27 | 2006-01-27 | Leader sequences for directing secretion of polypeptides and methods for production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1841874T3 true DK1841874T3 (da) | 2010-05-17 |
Family
ID=36741080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06719694.9T DK1841874T3 (da) | 2005-01-27 | 2006-01-27 | Leadersekvenser til at lede secernering af polypeptider og fremgangsmåder til fremstilling heraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080286834A1 (enExample) |
| EP (1) | EP1841874B1 (enExample) |
| JP (2) | JP2008528033A (enExample) |
| AT (1) | ATE454455T1 (enExample) |
| AU (1) | AU2006207999A1 (enExample) |
| CA (1) | CA2589895A1 (enExample) |
| DE (1) | DE602006011574D1 (enExample) |
| DK (1) | DK1841874T3 (enExample) |
| WO (1) | WO2006081430A2 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2083081A1 (en) | 2005-07-22 | 2009-07-29 | Five Prime Therapeutics, Inc. | Compositions and methods of treating disease with FGFR fusion proteins |
| JP5376948B2 (ja) | 2005-09-13 | 2013-12-25 | ナショナル リサーチ カウンシル オブ カナダ | 腫瘍細胞活性を調節する方法及び組成物 |
| US9060961B2 (en) * | 2006-11-09 | 2015-06-23 | University Of Washington | Molecules and methods for treatment and detection of cancer |
| WO2009056330A1 (en) * | 2007-10-31 | 2009-05-07 | Eth Zurich | Soluble truncated apom proteins and medical uses thereof |
| EP2271358B1 (en) * | 2008-03-25 | 2018-11-21 | Amarantus Therapeutics, Inc. | use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease |
| FR2933773B1 (fr) * | 2008-07-10 | 2013-02-15 | Biomerieux Sa | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal |
| RU2509774C2 (ru) | 2008-08-04 | 2014-03-20 | Файв Прайм Терапьютикс, Инк. | Мутеины кислотной зоны внеклеточного домена рецептора фактора роста фибробластов |
| US8470554B2 (en) * | 2008-12-22 | 2013-06-25 | St. Jude Children's Research Hospital | Prokaryotic expression of soluble, active Dkk |
| JP2010183885A (ja) * | 2009-02-13 | 2010-08-26 | Kobe Univ | タンパク質の製造方法およびそれに用いる発現ベクター |
| EP2478003A4 (en) | 2009-09-15 | 2013-05-29 | Five Prime Therapeutics Inc | HAIR GROWTH METHODS USING THE EXTRACELLULAR DOMAINS OF FGFR4 |
| US8614183B2 (en) | 2009-11-13 | 2013-12-24 | Five Prime Therapeutics, Inc. | Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2 |
| WO2011063523A1 (en) | 2009-11-24 | 2011-06-03 | Alethia Biotherapeutics Inc. | Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| EP2512501A4 (en) | 2009-12-17 | 2014-01-01 | Five Prime Therapeutics Inc | METHODS FOR PROMOTING HAIR GROWTH USING FGFR3 EXTRACELLULAR DOMAINS |
| AU2011248083B2 (en) | 2010-05-04 | 2015-09-10 | Five Prime Therapeutics, Inc. | Antibodies that bind CSF1R |
| US8431532B2 (en) | 2010-06-28 | 2013-04-30 | Five Prime Therepeutics, Inc. | FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same |
| EP2444495A1 (en) * | 2010-10-20 | 2012-04-25 | Algenics | Secretion of recombinant polypeptides in the extracellular medium of diatoms |
| US8481038B2 (en) | 2010-11-15 | 2013-07-09 | Five Prime Therapeutics, Inc. | Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| NZ703786A (en) | 2010-11-15 | 2016-08-26 | Five Prime Therapeutics Inc | Fgfr1 extracellular domain combination therapies |
| US8951972B2 (en) | 2010-12-09 | 2015-02-10 | Five Prime Therapeutics, Inc. | FGFR1 extracellular domain combination therapies for lung cancer |
| WO2012097238A2 (en) | 2011-01-14 | 2012-07-19 | Five Prime Therapeutics, Inc. | Il-27 antagonists for treating inflammatory diseases |
| CN107823630A (zh) | 2011-11-14 | 2018-03-23 | 戊瑞治疗有限公司 | 治疗癌症的方法 |
| CA2862739A1 (en) | 2012-02-22 | 2013-08-29 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| HK1208233A1 (en) | 2012-05-11 | 2016-02-26 | 戊瑞治疗有限公司 | Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) |
| MX2014015041A (es) | 2012-06-08 | 2015-06-17 | Shire Human Genetic Therapies | Administración pulmonar de arnm a células objetivo no pulmonares. |
| EP2890398A4 (en) | 2012-08-31 | 2016-03-09 | Five Prime Therapeutics Inc | METHODS OF TREATING DISEASES WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR RECEIVER 1 (CSF1R) |
| US20150366997A1 (en) | 2012-12-07 | 2015-12-24 | Shire Human Genetics Therapies, Inc. | COMPOSITIONS AND METHODS FOR mRNA DELIVERY |
| EP3431592A1 (en) | 2013-03-14 | 2019-01-23 | Translate Bio, Inc. | Mrna therapeutic compositions and use to treat diseases and disorders |
| PE20160190A1 (es) | 2013-08-01 | 2016-04-28 | Five Prime Therapeutics Inc | Anticuerpos anti-fgfr2iiib afucosilados |
| SG11201610672YA (en) | 2014-06-23 | 2017-01-27 | Five Prime Therapeutics Inc | Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) |
| US9765147B2 (en) | 2014-10-29 | 2017-09-19 | Five Prime Therapeutics, Inc. | Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer |
| CN107257806B (zh) | 2014-12-22 | 2021-08-10 | 戊瑞治疗有限公司 | 用于治疗pvns的抗csf1r抗体 |
| RS60614B1 (sr) | 2015-03-23 | 2020-08-31 | Jounce Therapeutics Inc | Antitela za icos |
| LT3283527T (lt) | 2015-04-13 | 2021-03-25 | Five Prime Therapeutics, Inc. | Kompleksinė terapija vėžio gydymui |
| US10968277B2 (en) | 2015-10-22 | 2021-04-06 | Jounce Therapeutics, Inc. | Gene signatures for determining ICOS expression |
| EP3448414B1 (en) | 2016-04-25 | 2024-04-17 | Five Prime Therapeutics, Inc. | Nope for treatment of pathological muscle loss and weakness |
| TWI781120B (zh) | 2016-11-02 | 2022-10-21 | 美商永斯醫療股份有限公司 | Ｐｄ-１之抗體及其用途 |
| CN109906030B (zh) | 2016-11-04 | 2022-03-18 | 安健基因公司 | 用于产生仅重链抗体的经基因修饰的非人动物和方法 |
| US20190330376A1 (en) * | 2016-12-29 | 2019-10-31 | Development Center For Biotechnology | Peptides derived from kininogen-1 for protein drugs in vivo half-life extensions |
| WO2018183608A1 (en) | 2017-03-31 | 2018-10-04 | Five Prime Therapeutics, Inc. | Combination therapy for cancer using anti-gitr antibodies |
| US20200024351A1 (en) | 2017-04-03 | 2020-01-23 | Jounce Therapeutics, Inc. | Compositions and Methods for the Treatment of Cancer |
| EP3634988A4 (en) | 2017-06-06 | 2021-02-24 | Kindred Biosciences, Inc. | ERYTHROPOIETIN AND SIMILAR COMPOUNDS FOR VETERINARY USE |
| JP7391868B2 (ja) | 2017-12-22 | 2023-12-05 | ジョウンセ セラピューティクス， インク． | Ｌｉｌｒｂ２に対する抗体 |
| AU2019302454A1 (en) | 2018-07-09 | 2021-02-25 | Bristol-Myers Squibb Company | Antibodies binding to ILT4 |
| WO2020146857A1 (en) * | 2019-01-11 | 2020-07-16 | Arbele Limited | Multispecific prochemokine therapeutic proteins (park) and method of making and using thereof |
| WO2021178001A1 (en) * | 2020-03-05 | 2021-09-10 | Curie Co. Inc. | Methods for cell free protein expression of mature polypeptides derived from zymogens and proproteins |
| BR112022014623A2 (pt) | 2020-02-14 | 2022-09-13 | Jounce Therapeutics Inc | Anticorpos e proteínas de fusão que se ligam a ccr8 e usos dos mesmos |
| CN116724051A (zh) | 2020-08-10 | 2023-09-08 | 上海寻百会生物技术有限公司 | 用于通过靶向igsf8来治疗自身免疫性疾病和癌症的组合物和方法 |
| WO2023235699A1 (en) | 2022-05-31 | 2023-12-07 | Jounce Therapeutics, Inc. | Antibodies to lilrb4 and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5712114A (en) * | 1995-06-06 | 1998-01-27 | Basf Aktiengesellschaft | Compositions for expression of proteins in host cells using a preprocollagen signal sequence |
| EP1105508B1 (en) * | 1998-08-17 | 2002-09-04 | Europäisches Laboratorium Für Molekularbiologie (Embl) | Method for purifying biomolecule or protein complexes |
| WO2005082934A2 (en) * | 2004-02-20 | 2005-09-09 | Five Prime Therapeutics, Inc. | Novel apo2l and il-24 polypeptides, polynucleotides, and methods of their use |
| US20070264277A1 (en) * | 2004-07-22 | 2007-11-15 | Dirk Behrens | Compositions and Methods of Use for Mgd-Csf in Disease Treatment |
-
2006
- 2006-01-27 WO PCT/US2006/002951 patent/WO2006081430A2/en not_active Ceased
- 2006-01-27 DK DK06719694.9T patent/DK1841874T3/da active
- 2006-01-27 JP JP2007553266A patent/JP2008528033A/ja active Pending
- 2006-01-27 US US11/883,065 patent/US20080286834A1/en not_active Abandoned
- 2006-01-27 EP EP06719694A patent/EP1841874B1/en not_active Not-in-force
- 2006-01-27 AT AT06719694T patent/ATE454455T1/de not_active IP Right Cessation
- 2006-01-27 CA CA002589895A patent/CA2589895A1/en not_active Abandoned
- 2006-01-27 AU AU2006207999A patent/AU2006207999A1/en not_active Abandoned
- 2006-01-27 DE DE602006011574T patent/DE602006011574D1/de active Active
-
2009
- 2009-01-19 JP JP2009009381A patent/JP2009131268A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006081430A3 (en) | 2007-04-05 |
| DE602006011574D1 (de) | 2010-02-25 |
| ATE454455T1 (de) | 2010-01-15 |
| CA2589895A1 (en) | 2006-08-03 |
| EP1841874B1 (en) | 2010-01-06 |
| JP2008528033A (ja) | 2008-07-31 |
| AU2006207999A1 (en) | 2006-08-03 |
| EP1841874A2 (en) | 2007-10-10 |
| JP2009131268A (ja) | 2009-06-18 |
| WO2006081430A9 (en) | 2006-11-30 |
| US20080286834A1 (en) | 2008-11-20 |
| WO2006081430A2 (en) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1841874T3 (da) | Leadersekvenser til at lede secernering af polypeptider og fremgangsmåder til fremstilling heraf | |
| PE20240728A1 (es) | Sistemas de represores de casx disenados por ingenieria genetica | |
| ATE512980T1 (de) | Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide | |
| AR074032A1 (es) | Polipeptidos de eritropoietina modificados y usos de los mismos. | |
| DK1240325T3 (da) | IL-17 og IL-17R homologe polypeptider og terapeutisk anvendelse deraf | |
| MX2022011180A (es) | Interruptores transcripcionales activados mediante union y metodos para su uso. | |
| ATE420970T1 (de) | Auf il-1-rezeptor beruhende antagonisten sowie herstellungs- und verwendungsverfahren | |
| ATE513907T1 (de) | Polypeptide mit endoglucanase-aktivität und polynukleotide zu ihrer kodierung | |
| MX2009005304A (es) | Polipeptidos heterodimericos il-17a/f y usos terapeuticos de los mismos. | |
| CL2008001156A1 (es) | Metodo para producir una proteina de fusion tnfr en un cultivo celular que comprende cultivar celulas de mamifero que contienen un gen que codifica la proteina de fusion en un medio de cultivo de celulas que comprende un compuesto anti-envejecimiento. | |
| ATE478145T1 (de) | Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren | |
| GT201000148A (es) | Anticuerpos antimesotelina y usos de los mismos | |
| CY1110939T1 (el) | Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης | |
| NZ596735A (en) | Recombinant production of peptides | |
| MX394262B (es) | Uso de sintasas de octacetido para producir acido kermesico y acido flavokermesico. | |
| PT2170942E (pt) | Clone celular produtor de fsh | |
| WO2010018444A3 (en) | An expression vector and a method thereof | |
| EA201691548A1 (ru) | Экспрессирующие конструкции и способы для отбора клеток-хозяев, экспрессирующих полипептиды | |
| ATE515568T1 (de) | Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide | |
| WO2006053021A3 (en) | Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby | |
| MX345294B (es) | Polipéptidos de unión quimérica de plantas para reconocimiento molecular universal. | |
| DK2145006T3 (da) | Ekspressionssystem anvendt til antibiotikafri fremstilling af polypeptider | |
| ATE532861T1 (de) | Expressionsvektor | |
| NZ586037A (en) | Sm-protein based secretion engineering | |
| ATE534754T1 (de) | Selektion kodierender nukleinsäure-konstrukte auf abwesenheit von frameshift-mutationen |